Generative approach trained on UK and Danish dat

Company advances candidate targeting senescent c

Barcelona-based INBRAIN Neuroelectronics, a compa

Annovis Bio, Inc.

HCW Biologics, a clinical-stage biopharmaceutical

Genflow Biosciences has entered into two Confiden

BioAge Labs, in partnership with HitGen, has init

Alterity Therapeutics has disclosed results from

Mesoblast has reported that the commercial launch

Phoenix and Eos SENOLYTIX to present dual approa

Longevity enthusiast Michael Martin on bridging

Big Pharma leaders embrace GLP-1s as longevity d

New partnership aims to put epigenetic testing d

Neu Health, a precision neurology platform focuse

Cross-licensing agreement brings reformulated ri

XPRIZE Healthspan EVP Jamie Justice explains why

Eleanor Davies, Global DeSci Lead at Sei Develop

FibroBiologics, Inc.

Maze Therapeutics has announced positive results

How a ‘special economic zone’ is enabling on

Two conferences in Riga and Vilnius bring scienc

Aviv Clinics announced a new retrospective cohort

Anavex Life Sciences has announced findings from

Alchemab Therapeutics today announced that it has

XPRIZE Health EVP Dr Jamie Justice on tackling o

Founder and CEO Kevin Slawin MD recommends new,

Beauty giant Beiersdorf joins investors in longe

Tolerance Bio and ZipCode Bio have launched a str

Biosplice Therapeutics has announced that the fir

HCW Biologics Inc.

Thorne, the science-backed health and wellness br

Serina Therapeutics has entered into an agreement

The U.S.

Telomir Pharmaceuticals has released new preclini

NRG Therapeutics has closed an oversubscribed £5

A new real-world analysis by Omada Health finds t

Biomed Industries will present results from its P

C2N Diagnostics announced it has secured a $1 mil

Turn Biotechnologies, a California-based company

Mountain View, CA – Google has established a ne

Life Biosciences has in‑licensed intellectual p

C2N Diagnostics has widened the intended use of i

PhysioAge Health Analytics CEO on using biomarke

Anderson Longevity Clinic expands with new franch

Immunis Inc.

BioAge, a Richmond, California–based biotechnol

Aspen Neuroscience has completed dose escalation

Haya Therapeutics, a biotech firm pioneering prec

Revalia Bio lands funding to scale up drug testi

Investment from Allen Law’s Seveno Capital ref